Re: Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder

European Urology

Volumn 61, Issue 4, 2012, Pages 847-848

  Oliva Encina, José ^a   Rioja Sanz, Carlos ^a  

^a Hospital RoyoVillanova   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; BCG VACCINE;

BLADDER CARCINOMA; CARCINOMA IN SITU; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FLUORESCENCE; FLUORESCENCE CYSTOSCOPY; HUMAN; INTERMETHOD COMPARISON; NOTE; PRIORITY JOURNAL; WHITE LIGHT;

EID: 84857608833     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.01.033     Document Type: Note

References (5)

1. D. Wallace, J. Hindmarsh, and J. Webb The role of multiple mucosal biopsies in the management of patients with bladder cancer Br J Urol 51 1979 535 540 (Pubitemid 10164557)
2. J. Oliva Encina, and C. Rioja Sanz Photodynamic diagnosis (PDD) in non-muscle invasive bladder cancer. Literature review Actas Urol Esp 33 2009 965 975
3. J.P. Burgués, G. Conde, J. Oliva Grupo BLUE (Blue Light Urologic Endoscopy) Hexaminolevulinate photodynamic diagnosis in non-muscle invasive bladder cancer: experience of the BLUE Group Actas Urol Esp 35 2011 439 445
4. Y. Uekado, Y. Kohjimoto, A. Iba, K. Kikkawa, Y. Shintani, and T. Shinka Efficacy of intravesical bacillus Calmette-Guérin for carcinoma in situ of bladder Hinyokika Kiyo 52 2006 439 444 (Pubitemid 44014596)
5. Y. Fradet, H.B. Grossman, L. Gomella PC B302/01 Study Group A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study J Urol 178 2007 68 73 (Pubitemid 46908730)